S&P 500   4,277.01 (+0.07%)
DOW   33,899.55 (-0.24%)
QQQ   328.75 (+0.08%)
AAPL   173.88 (-0.38%)
MSFT   290.53 (-0.27%)
META   174.50 (-0.20%)
GOOGL   120.03 (+0.40%)
AMZN   142.21 (+0.08%)
TSLA   911.05 (-0.10%)
NVDA   186.76 (+1.86%)
NIO   19.84 (-1.20%)
BABA   90.41 (+0.71%)
AMD   100.33 (+2.10%)
MU   62.82 (+1.95%)
T   18.41 (-0.05%)
CGC   3.78 (-6.90%)
F   16.00 (-0.19%)
GE   79.05 (-1.09%)
DIS   122.23 (-0.47%)
AMC   20.01 (-6.32%)
PYPL   98.59 (-0.83%)
PFE   48.48 (-1.60%)
NFLX   244.66 (+1.46%)
S&P 500   4,277.01 (+0.07%)
DOW   33,899.55 (-0.24%)
QQQ   328.75 (+0.08%)
AAPL   173.88 (-0.38%)
MSFT   290.53 (-0.27%)
META   174.50 (-0.20%)
GOOGL   120.03 (+0.40%)
AMZN   142.21 (+0.08%)
TSLA   911.05 (-0.10%)
NVDA   186.76 (+1.86%)
NIO   19.84 (-1.20%)
BABA   90.41 (+0.71%)
AMD   100.33 (+2.10%)
MU   62.82 (+1.95%)
T   18.41 (-0.05%)
CGC   3.78 (-6.90%)
F   16.00 (-0.19%)
GE   79.05 (-1.09%)
DIS   122.23 (-0.47%)
AMC   20.01 (-6.32%)
PYPL   98.59 (-0.83%)
PFE   48.48 (-1.60%)
NFLX   244.66 (+1.46%)
S&P 500   4,277.01 (+0.07%)
DOW   33,899.55 (-0.24%)
QQQ   328.75 (+0.08%)
AAPL   173.88 (-0.38%)
MSFT   290.53 (-0.27%)
META   174.50 (-0.20%)
GOOGL   120.03 (+0.40%)
AMZN   142.21 (+0.08%)
TSLA   911.05 (-0.10%)
NVDA   186.76 (+1.86%)
NIO   19.84 (-1.20%)
BABA   90.41 (+0.71%)
AMD   100.33 (+2.10%)
MU   62.82 (+1.95%)
T   18.41 (-0.05%)
CGC   3.78 (-6.90%)
F   16.00 (-0.19%)
GE   79.05 (-1.09%)
DIS   122.23 (-0.47%)
AMC   20.01 (-6.32%)
PYPL   98.59 (-0.83%)
PFE   48.48 (-1.60%)
NFLX   244.66 (+1.46%)
S&P 500   4,277.01 (+0.07%)
DOW   33,899.55 (-0.24%)
QQQ   328.75 (+0.08%)
AAPL   173.88 (-0.38%)
MSFT   290.53 (-0.27%)
META   174.50 (-0.20%)
GOOGL   120.03 (+0.40%)
AMZN   142.21 (+0.08%)
TSLA   911.05 (-0.10%)
NVDA   186.76 (+1.86%)
NIO   19.84 (-1.20%)
BABA   90.41 (+0.71%)
AMD   100.33 (+2.10%)
MU   62.82 (+1.95%)
T   18.41 (-0.05%)
CGC   3.78 (-6.90%)
F   16.00 (-0.19%)
GE   79.05 (-1.09%)
DIS   122.23 (-0.47%)
AMC   20.01 (-6.32%)
PYPL   98.59 (-0.83%)
PFE   48.48 (-1.60%)
NFLX   244.66 (+1.46%)
OTCMKTS:DGCRF

9342-8530 Québec - DGCRF Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
23,332 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About 9342-8530 Québec

9342-8530 Québec Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada. It focuses on molecular diagnostic tests for the detection and management of cancer. The company offers PCA3 test for the diagnosis of prostate cancer; and Guanylyl Cyclase C (GCC) marker and Previstage GCC colorectal cancer staging test for colorectal cancer patients, as well as PCP, a multi marker prostate cancer test. It also provides gene expression and copy number variation analysis, mutation detection, SNP genotyping, and platform and laboratory environmental services. The company was formerly known as DiagnoCure Inc. 9342-8530 Québec Inc. was founded in 1994 and is headquartered in Quebec, Canada.

Receive DGCRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 9342-8530 Québec and its competitors with MarketBeat's FREE daily newsletter.

DGCRF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive DGCRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 9342-8530 Québec and its competitors with MarketBeat's FREE daily newsletter.

DGCRF Company Calendar

Last Earnings
1/16/2014
Today
8/18/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:DGCRF
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Yves Fradet (Age 70)
    Co-Founder, Pres and Chief Medical Officer
    Comp: $103.74k
  • Mr. Pierre Lapalme (Age 80)
    Advisor to the Pres
  • Mr. Pierre Désy
    Consulting Advisor to the Pres
  • Mr. Andrew J. Sheldon
    Adviser













DGCRF Stock - Frequently Asked Questions

How were 9342-8530 Québec's earnings last quarter?

9342-8530 Québec Inc. (OTCMKTS:DGCRF) issued its earnings results on Thursday, January, 16th. The company reported ($0.03) earnings per share for the quarter.

What is 9342-8530 Québec's stock symbol?

9342-8530 Québec trades on the OTCMKTS under the ticker symbol "DGCRF."

How can I contact 9342-8530 Québec?

The official website for the company is www.diagnocure.com. The company can be reached via phone at 418-527-6100.

This page (OTCMKTS:DGCRF) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.